NeuroMetrix Showcases Quell™ Wearable Pain Relief Technology at the PAINWeek National Conference

BOSTON--()--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable Pain Relief Technology will be featured at the PAINWeek 2015 National Conference this week in Las Vegas, Nevada. PAINWeek is the nation’s largest pain conference for frontline clinicians with an interest in pain management. Over 2100 physicians and other health care professionals are expected to attend.

"Quell is an ideal option for pain medicine physicians managing challenging chronic pain conditions such as painful diabetic neuropathy, sciatica and fibromyalgia," said Shai N. Gozani, M.D., Ph.D. President and CEO of NeuroMetrix, Inc. "The PAINWeek meeting is a great venue to share Quell technology and our latest clinical data with the pain management community."

A study abstract, "Treatment of Chronic Pain with a Novel Wearable Transcutaneous Electrical Nerve Stimulator," was accepted for poster presentation at the conference scientific sessions. Dr. Gozani will present the study results at the Poster Reception on September 10.

About Quell Wearable Pain Relief Device

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's wearable intensive nerve stimulation (WINS) technology to provide pain relief. Quell is currently available through select healthcare professionals and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts

Investor Relations:
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Contacts

Investor Relations:
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com